rs7663712
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_002039.4(GAB1):c.72+2704A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0458 in 152,312 control chromosomes in the GnomAD database, including 179 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.046 ( 179 hom., cov: 33)
Consequence
GAB1
NM_002039.4 intron
NM_002039.4 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.0730
Publications
3 publications found
Genes affected
GAB1 (HGNC:4066): (GRB2 associated binding protein 1) The protein encoded by this gene is a member of the IRS1-like multisubstrate docking protein family. It is an important mediator of branching tubulogenesis and plays a central role in cellular growth response, transformation and apoptosis. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2008]
GAB1 Gene-Disease associations (from GenCC):
- autosomal recessive nonsyndromic hearing loss 26Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.94).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.0515 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| GAB1 | ENST00000262994.9 | c.72+2704A>G | intron_variant | Intron 1 of 9 | 1 | NM_002039.4 | ENSP00000262994.4 | |||
| GAB1 | ENST00000262995.9 | c.72+2704A>G | intron_variant | Intron 1 of 10 | 1 | ENSP00000262995.4 | ||||
| GAB1 | ENST00000514639.6 | c.72+2704A>G | intron_variant | Intron 1 of 10 | 3 | ENSP00000427435.2 |
Frequencies
GnomAD3 genomes AF: 0.0458 AC: 6970AN: 152194Hom.: 179 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
6970
AN:
152194
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.0458 AC: 6980AN: 152312Hom.: 179 Cov.: 33 AF XY: 0.0444 AC XY: 3305AN XY: 74490 show subpopulations
GnomAD4 genome
AF:
AC:
6980
AN:
152312
Hom.:
Cov.:
33
AF XY:
AC XY:
3305
AN XY:
74490
show subpopulations
African (AFR)
AF:
AC:
1929
AN:
41580
American (AMR)
AF:
AC:
655
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
AC:
145
AN:
3472
East Asian (EAS)
AF:
AC:
68
AN:
5186
South Asian (SAS)
AF:
AC:
263
AN:
4824
European-Finnish (FIN)
AF:
AC:
196
AN:
10620
Middle Eastern (MID)
AF:
AC:
19
AN:
294
European-Non Finnish (NFE)
AF:
AC:
3600
AN:
68010
Other (OTH)
AF:
AC:
102
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
346
692
1037
1383
1729
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
84
168
252
336
420
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
123
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.